NCPA's qAM

qAM

Don't delay: contact your senators to urge their support for DIR reform

by NCPA | Jun 13, 2019

Please contact your senators immediately and ask that they voice support to the Senate Finance Committee for inclusion of provisions addressing pharmacy DIR fees in drug pricing legislation the committee is expected to consider in the very near future.

The Committee could consider the legislation as soon as June 19, so please take immediate action because:

  • Pharmacy DIR fees have increased 45,000 percent since 2010.

  • Pharmacy DIR fees continue to be unpredictable for pharmacies.

  • DIR fees force patients into the coverage gap prematurely, which creates financial hardship for patients.

  • DIR fees must be expeditiously addressed by Congress given CMS' failure to act.

Thank you for your prompt action in support of community pharmacy's top priority issue.